Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diseases of the Thyroid

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 28 articles:
HTML format
Text format



Single Articles


    June 2018
  1. KIM YJ, Hwang HJ, Kang JG, Kim CS, et al
    Enigma Plays Roles in Survival of Thyroid Carcinoma Cells through PI3K/AKT Signaling and Survivin.
    Anticancer Res. 2018;38:3515-3525.
    PubMed     Text format     Abstract available


  2. GADDUCCI A, Pistolesi S, Guerrieri ME, Cosio S, et al
    Malignant Transformation in Mature Cystic Teratomas of the Ovary: Case Reports and Review of the Literature.
    Anticancer Res. 2018;38:3669-3675.
    PubMed     Text format     Abstract available


    May 2018
  3. SHIH YL, Huang YH, Lin KH, Chu YD, et al
    Identification of Functional Thyroid Stimulating Hormone Receptor and TSHR Gene Mutations in Hepatocellular Carcinoma.
    Anticancer Res. 2018;38:2793-2802.
    PubMed     Text format     Abstract available


    April 2018
  4. DZIGGEL L, Gebauer N, Bartscht T, Schild SE, et al
    Performance Status and Number of Metastatic Extra-cerebral Sites Predict Survival After Radiotherapy of Brain Metastases from Thyroid Cancer.
    Anticancer Res. 2018;38:2391-2394.
    PubMed     Text format     Abstract available


    March 2018
  5. NERVO A, Gallo M, Sama MT, Felicetti F, et al
    Lenvatinib in Advanced Radioiodine-refractory Thyroid Cancer: A Snapshot of Real-life Clinical Practice.
    Anticancer Res. 2018;38:1643-1649.
    PubMed     Text format     Abstract available


    January 2018
  6. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Computed Tomography Density Change in the Thyroid Gland Before and After Radiation Therapy.
    Anticancer Res. 2018;38:417-421.
    PubMed     Text format     Abstract available


    October 2017

  7. Thyroid Cancer and Nuclear Accidents. 1st Edition.
    Anticancer Res. 2017;37:5908.
    PubMed     Text format    


  8. DO SI, Kim HS, Kim K, Lee H, et al
    Predictive Value of Sphingosine Kinase 1 Expression in Papillary Thyroid Carcinoma.
    Anticancer Res. 2017;37:5399-5405.
    PubMed     Text format     Abstract available


    September 2017
  9. WOJTCZAK B, Pula B, Gomulkiewicz A, Olbromski M, et al
    Metallothionein Isoform Expression in Benign and Malignant Thyroid Lesions.
    Anticancer Res. 2017;37:5179-5185.
    PubMed     Text format     Abstract available


  10. AMPIL F, Ellika S, Nanda A, Vora M, et al
    Long-term Survival After Stereotactic Radiosurgery of Brain Metastases: A Case Series with 10-year Follow-up.
    Anticancer Res. 2017;37:5113-5115.
    PubMed     Text format     Abstract available


    April 2017
  11. JO S, Ha TK, Han SH, Kim ME, et al
    Myricetin Induces Apoptosis of Human Anaplastic Thyroid Cancer Cells via Mitochondria Dysfunction.
    Anticancer Res. 2017;37:1705-1710.
    PubMed     Text format     Abstract available


    March 2017
  12. RUSSO M, Malandrino P, Moleti M, D'Angelo A, et al
    Thyroid Cancer in the Pediatric Age in Sicily: Influence of the Volcanic Environment.
    Anticancer Res. 2017;37:1515-1522.
    PubMed     Text format     Abstract available


    January 2017

  13. Thyroid Cancer. A Comprehensive Guide to Clinical Management. Third Edition.
    Anticancer Res. 2017;37:361.
    PubMed     Text format    


    October 2016
  14. DAMASKOS C, Valsami S, Spartalis E, Antoniou EA, et al
    Histone Deacetylase Inhibitors: A Novel Therapeutic Weapon Against Medullary Thyroid Cancer?
    Anticancer Res. 2016;36:5019-5024.
    PubMed     Text format     Abstract available


    September 2016
  15. KASMANN L, Bolm L, Janssen S, Rades D, et al
    Prognostic Factors for Survival in Patients Treated with Multimodal Therapy for Anaplastic Thyroid Cancer.
    Anticancer Res. 2016;36:4697-700.
    PubMed     Text format     Abstract available


    August 2016
  16. KARAGIANNIS AK, Girio-Fragkoulakis C, Nakouti T
    Procalcitonin: A New Biomarker for Medullary Thyroid Cancer? A Systematic Review.
    Anticancer Res. 2016;36:3803-10.
    PubMed     Text format     Abstract available


    July 2016
  17. KASMANN L, Janssen S, Rades D
    Prognostic Factors Including the Expression of Thyroid Transcription Factor 1 (TTF1) in Patients Irradiated for Limited-disease Small Cell Lung Cancer.
    Anticancer Res. 2016;36:3499-503.
    PubMed     Text format     Abstract available


    June 2016
  18. KOLBEN T, Hary T, Holdt LM, Schwarz TM, et al
    Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes.
    Anticancer Res. 2016;36:3185-90.
    PubMed     Text format     Abstract available


  19. MEGWALU UC, Green RW
    Total Thyroidectomy Versus Lobectomy for the Treatment of Follicular Thyroid Microcarcinoma.
    Anticancer Res. 2016;36:2899-902.
    PubMed     Text format     Abstract available


    April 2016
  20. RADES D, Janssen S, Kasmann L, Bolm L, et al
    Outcomes After Irradiation of Epidural Spinal Cord Compression Due to Metastatic Thyroid Cancer.
    Anticancer Res. 2016;36:2035-9.
    PubMed     Text format     Abstract available


    February 2016
  21. LONDERO SC, Jespersen ML, Krogdahl A, Bastholt L, et al
    Gene-expression Classifier in Papillary Thyroid Carcinoma: Validation and Application of a Classifier for Prognostication.
    Anticancer Res. 2016;36:749-56.
    PubMed     Text format     Abstract available


    December 2015
  22. PAPADAKIS G, Kalaitzidou S, Triantafillou E, Drosou A, et al
    Biochemical Effects of Levothyroxine Withdrawal in Patients with Differentiated Thyroid Cancer.
    Anticancer Res. 2015;35:6933-40.
    PubMed     Text format     Abstract available


  23. KIM SH, Kang JG, Kim CS, Ihm SH, et al
    Suppression of AKT Potentiates Synergistic Cytotoxicity of Apigenin with TRAIL in Anaplastic Thyroid Carcinoma Cells.
    Anticancer Res. 2015;35:6529-37.
    PubMed     Text format     Abstract available


    November 2015
  24. KUST D, Matesa N, Kusic Z
    Clinical Significance of Multinodularity in Patients with Papillary Thyroid Carcinoma.
    Anticancer Res. 2015;35:6335-9.
    PubMed     Text format     Abstract available


    October 2015
  25. KIM SH, Kang JG, Kim CS, Ihm SH, et al
    17-Allylamino-17-demethoxygeldanamycin and Herbimycin A Induce Cell Death by Modulating beta-Catenin and PI3K/AKT Signaling in FRO Anaplastic Thyroid Carcinoma Cells.
    Anticancer Res. 2015;35:5453-60.
    PubMed     Text format     Abstract available


  26. SUROV A, Gottschling S, Wienke A, Meyer HJ, et al
    Primary Thyroid Sarcoma: A Systematic Review.
    Anticancer Res. 2015;35:5185-91.
    PubMed     Text format     Abstract available


    July 2015
  27. PAPADAKIS G, Keramidas I, Triantafillou E, Kanouta F, et al
    Association of Basal and Calcium-stimulated Calcitonin Levels with Pathological Findings After Total Thyroidectomy.
    Anticancer Res. 2015;35:4251-8.
    PubMed     Text format     Abstract available


  28. SUGITA K, Kawakami K, Yokokawa T, Mae Y, et al
    Investigation of Regorafenib-induced Hypothyroidism in Patients with Metastatic Colorectal Cancer.
    Anticancer Res. 2015;35:4059-62.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: